# Delcath Systems

Type: Company (DCTH)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/delcath-systems
Canonical HTML page: https://gethealthbrief.com/entity/delcath-systems

## Recent coverage (1 stories)

### MedTech and Specialty Pharma Braced for High-Stakes Q4 2025 Results
2026-02-25 15:05:48 · Sentiment: Neutral · Impact: 5/10 · Sources: 4

Delcath Systems, Lantheus Holdings, Butterfly Network, and Heron Therapeutics are preparing to report Q4 2025 earnings, marking a critical test for commercial-stage medical innovators. Investors are laser-focused on the adoption rates of flagship products like HEPZATO KIT and PYLARIFY as these companies navigate a complex reimbursement environment.
Full story: https://gethealthbrief.com/story/medtech-specialty-pharma-q4-2025-earnings-preview

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.